Applied BioCode Receivables

The latest receivables for 6598.TW is $160M as of June 2026. That compares with $84M in the prior-year period — up 91.9% year over year. Investors often review this figure alongside Applied BioCode's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6598.TW's receivables moved from $84M to $160M — a 91.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Applied BioCode's operating scale or balance-sheet position.

A receivables figure of $160M for 6598.TW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6598.TW's receivables ($160M), review year-over-year change from $84M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.